Oral contraceptive use alters the balance of platelet prostaglandin and thromboxane synthesis.
The ability of platelet microsomes to generate platelet aggregating activity on addition of arachidonic acid was evaluated in women taking oral contraceptives and in controls taking no medication but matched for age, sex, and family history. Oral contraceptive users generated significantly more platelet aggregating activity per 100 ug of platelet microsomal protein than controls. Variation in generation of platelet aggregating activity during the menstrual cycle was also observed with highest activity during the third week. These studies show an altered balance of platelet prostaglandin and thromboxane synthesis in oral contraceptive users which may contribute to their increased incidence of thromboembolic phenomena.
D000328:Adult; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism*; D003276:Contraceptives, Oral / Q000494:pharmacology*; D003277:Contraceptives, Oral, Combined / Q000494:pharmacology; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008598:Menstruation; D008861:Microsomes / Q000187:drug effects / Q000378:metabolism; D010974:Platelet Aggregation / Q000187:drug effects; D011453:Prostaglandins / Q000096:biosynthesis / Q000097:blood*; D013931:Thromboxanes / Q000096:biosynthesis / Q000097:blood*
D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D011453:Prostaglandins; D013931:Thromboxanes